Ventricular tachycardia burden reduction after substrate ablation: predictors of recurrence.
Sign Up to like & getrecommendations! Published in 2021 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2021.02.016
Abstract: BACKGROUND Substrate-based ventricular tachycardia (VT) ablation is a first-line treatment in patients with structural cardiac disease with sustained VT refractory to medical therapy. Despite technological improvements and increased knowledge of VT substrate, recurrence is still… read more here.
Keywords: reduction; recurrence; ablation; substrate ablation ... See more keywords
Mini-electrodes help identifying hidden slow conduction during ventricular tachycardia substrate ablation.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of electrocardiology"
DOI: 10.1016/j.jelectrocard.2018.08.016
Abstract: A 69-year-old male with dilated non-ischemic cardiomyopathy and history of sustained monomorphic VT (SMVT) underwent an unsuccessful VT substrate ablation due to the proximity of the earliest activation site to the conduction system. A second… read more here.
Keywords: ablation; slow conduction; substrate ablation; hidden slow ... See more keywords
Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease
Sign Up to like & getrecommendations! Published in 2022 at "Circulation"
DOI: 10.1161/circulationaha.122.060882
Abstract: Background: Ablation of ventricular tachycardia (VT) in the setting of structural heart disease often requires extensive substrate elimination that is not always achievable by endocardial radiofrequency ablation. Epicardial ablation is not always feasible. Case reports… read more here.
Keywords: structural heart; ablation; heart disease; substrate ablation ... See more keywords